Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 5359768, 10 pages
http://dx.doi.org/10.1155/2016/5359768
Research Article

Serotonin-Exacerbated DSS-Induced Colitis Is Associated with Increase in MMP-3 and MMP-9 Expression in the Mouse Colon

1Department of Gastroenterology and Hepatology, The First Affiliated Hospital and College of Clinical Medicine, Henan University of Science and Technology, Luoyang 471003, China
2Department of Clinical Laboratory, The First Affiliated Hospital and College of Clinical Medicine, Henan University of Science and Technology, Luoyang 471003, China
3Department of Cancer Genetics and Epigenetics, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA
4Department of Gastroenterology and Hepatology, Beijing Rehabilitation Hospital of Capital Medical University, 1 Gongliao Road, Shijingshan District, Beijing 100114, China

Received 3 March 2016; Revised 24 April 2016; Accepted 29 May 2016

Academic Editor: Mirella Giovarelli

Copyright © 2016 Menglu Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Kaser, S. Zeissig, and R. S. Blumberg, “Inflammatory bowel disease,” Annual Review of Immunology, vol. 28, pp. 573–621, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. S. I. Grivennikov, “Inflammation and colorectal cancer: colitis-associated neoplasia,” Seminars in Immunopathology, vol. 35, no. 2, pp. 229–244, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Terzić, S. Grivennikov, E. Karin, and M. Karin, “Inflammation and colon cancer,” Gastroenterology, vol. 138, no. 6, pp. 2101–2114.e5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. K. L. Wallace, L.-B. Zheng, Y. Kanazawa, and D. Q. Shih, “Immunopathology of inflammatory bowel disease,” World Journal of Gastroenterology, vol. 20, no. 1, pp. 6–21, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. Y.-Z. Zhang and Y.-Y. Li, “Inflammatory bowel disease: pathogenesis,” World Journal of Gastroenterology, vol. 20, no. 1, pp. 91–99, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. D. J. Walther and M. Bader, “A unique central tryptophan hydroxylase isoform,” Biochemical Pharmacology, vol. 66, no. 9, pp. 1673–1680, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Bertaccini, “Tissue 5-hydroxytryptamine and urinary 5-hydroxyindoleacetic acid after partial or total removal of the gastro-intestinal tract in the rat,” The Journal of Physiology, vol. 153, no. 2, pp. 239–249, 1960. View at Publisher · View at Google Scholar
  8. M. D. Gershon, A. B. Drakontides, and L. L. Ross, “Serotonin: synthesis and release from the myenteric plexus of the mouse intestine,” Science, vol. 149, no. 3680, pp. 197–199, 1965. View at Publisher · View at Google Scholar · View at Scopus
  9. P. M. Whitaker-Azmitia, “The discovery of serotonin and its role in neuroscience,” Neuropsychopharmacology, vol. 21, supplement 2, pp. 2S–8S, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. G. M. Mawe and J. M. Hoffman, “Serotonin signalling in the gut-functions, dysfunctions and therapeutic targets,” Nature Reviews Gastroenterology and Hepatology, vol. 10, no. 8, pp. 473–486, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Arreola, E. Becerril-Villanueva, C. Cruz-Fuentes et al., “Immunomodulatory effects mediated by serotonin,” Journal of Immunology Research, vol. 2015, Article ID 354957, 21 pages, 2015. View at Publisher · View at Google Scholar
  12. P. R. Wade, J. Chen, B. Jaffe, I. S. Kassem, R. D. Blakely, and M. D. Gershon, “Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract,” The Journal of Neuroscience, vol. 16, no. 7, pp. 2352–2364, 1996. View at Google Scholar · View at Scopus
  13. D. Hoyer, J. P. Hannon, and G. R. Martin, “Molecular, pharmacological and functional diversity of 5-HT receptors,” Pharmacology Biochemistry and Behavior, vol. 71, no. 4, pp. 533–554, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Hannon and D. Hoyer, “Molecular biology of 5-HT receptors,” Behavioural Brain Research, vol. 195, no. 1, pp. 198–213, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. D. Coates, C. R. Mahoney, D. R. Linden et al., “Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome,” Gastroenterology, vol. 126, no. 7, pp. 1657–1664, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. I. M. Minderhoud, B. Oldenburg, M. E. I. Schipper, J. J. M. ter Linde, and M. Samsom, “Serotonin synthesis and uptake in symptomatic patients with Crohn's disease in remission,” Clinical Gastroenterology and Hepatology, vol. 5, no. 6, pp. 714–720, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. I. I. Stoyanova and M. V. Gulubova, “Mast cells and inflammatory mediators in chronic ulcerative colitis,” Acta Histochemica, vol. 104, no. 2, pp. 185–192, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. C. P. Bearcroft, D. Perrett, and M. J. G. Farthing, “Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study,” Gut, vol. 42, no. 1, pp. 42–46, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. R. C. Spiller, D. Jenkins, J. P. Thornley et al., “Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome,” Gut, vol. 47, no. 6, pp. 804–811, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. M. El-Salhy, Å. Danielsson, R. Stenling, and L. Grimelius, “Colonic endocrine cells in inflammatory bowel disease,” Journal of Internal Medicine, vol. 242, no. 5, pp. 413–419, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. P. P. Bertrand, A. Barajas-Espinosa, S. Neshat, R. L. Bertrand, and A. E. Lomax, “Analysis of real-time serotonin (5-HT) availability during experimental colitis in mouse,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 298, no. 3, pp. G446–G455, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. C. Regmi, S.-Y. Park, S. K. Ku, and J.-A. Kim, “Serotonin regulates innate immune responses of colon epithelial cells through Nox2-derived reactive oxygen species,” Free Radical Biology and Medicine, vol. 69, pp. 377–389, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-E. Ghia, N. Li, H. Wang et al., “Serotonin has a key role in pathogenesis of experimental colitis,” Gastroenterology, vol. 137, no. 5, pp. 1649–1660, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Visse and H. Nagase, “Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry,” Circulation Research, vol. 92, no. 8, pp. 827–839, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Nagaset and J. F. Woessner Jr., “Matrix metalloproteinases,” The Journal of Biological Chemistry, vol. 274, no. 31, pp. 21491–21494, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Klein and R. Bischoff, “Physiology and pathophysiology of matrix metalloproteases,” Amino Acids, vol. 41, no. 2, pp. 271–290, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. R. P. Iyer, N. L. Patterson, G. B. Fields, and M. L. Lindsey, “The history of matrix metalloproteinases: milestones, myths, and misperceptions,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 303, no. 8, pp. H919–H930, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. S. S. Apte and W. C. Parks, “Metalloproteinases: a parade of functions in matrix biology and an outlook for the future,” Matrix Biology, vol. 44–46, pp. 1–6, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Brew and H. Nagase, “The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity,” Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, vol. 1803, no. 1, pp. 55–71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Murphy, “Tissue inhibitors of metalloproteinases,” Genome Biology, vol. 12, no. 11, p. 233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. Q. Gao, M. J. W. Meijer, F. J. G. M. Kubben et al., “Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases,” Digestive and Liver Disease, vol. 37, no. 8, pp. 584–592, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Medina and M. W. Radomski, “Role of matrix metalloproteinases in intestinal inflammation,” Journal of Pharmacology and Experimental Therapeutics, vol. 318, no. 3, pp. 933–938, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. M. D. Baugh, M. J. Perry, A. P. Hollander et al., “Matrix metalloproteinase levels are elevated in inflammatory bowel disease,” Gastroenterology, vol. 117, no. 4, pp. 814–822, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Garg, M. Vijay-Kumar, L. Wang, A. T. Gewirtz, D. Merlin, and S. V. Sitaraman, “Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 296, no. 2, pp. G175–G184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Hadler-Olsen, B. Fadnes, I. Sylte, L. Uhlin-Hansen, and J.-O. Winberg, “Regulation of matrix metalloproteinase activity in health and disease,” The FEBS Journal, vol. 278, no. 1, pp. 28–45, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Warstat, T. Pap, G. Klein, S. Gay, and W. K. Aicher, “Co-activation of synovial fibroblasts by laminin-111 and transforming growth factor-β induces expression of matrix metalloproteinases 3 and 10 independently of nuclear factor-κB,” Annals of the Rheumatic Diseases, vol. 67, no. 4, pp. 559–562, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Unoki, H. Bujo, M. Jiang, T. Kawamura, K. Murakami, and Y. Saito, “Macrophages regulate tumor necrosis factor-α expression in adipocytes through the secretion of matrix metalloproteinase-3,” International Journal of Obesity, vol. 32, no. 6, pp. 902–911, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Hanemaaijer, P. Koolwijk, L. Le Clercq, W. J. A. De Vree, and V. W. M. Van Hinsbergh, “Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells: effects of tumour necrosis factor α, interleukin 1 and phorbol ester,” Biochemical Journal, vol. 296, no. 3, pp. 803–809, 1993. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Blindt, F. Vogt, D. Lamby et al., “Characterization of differential gene expression in quiescent and invasive human arterial smooth muscle cells,” Journal of Vascular Research, vol. 39, no. 4, pp. 340–352, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Kofla-Dlubacz, M. Matusiewicz, M. Krzystek-Korpacka, and B. Iwanczak, “Correlation of MMP-3 and MMP-9 with crohn's disease activity in children,” Digestive Diseases and Sciences, vol. 57, no. 3, pp. 706–712, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. S. O'Sullivan, J. F. Gilmer, and C. Medina, “Matrix metalloproteinases in inflammatory bowel disease: an update,” Mediators of Inflammation, vol. 2015, Article ID 964131, 19 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Kothari, R. Pestana, R. Mesraoua et al., “IL-6-mediated induction of matrix metalloproteinase-9 is modulated by JAK-dependent IL-10 expression in macrophages,” Journal of Immunology, vol. 192, no. 1, pp. 349–357, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Li, S. Dubey, M. L. Varney, B. J. Dave, and R. K. Singh, “IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis,” The Journal of Immunology, vol. 170, no. 6, pp. 3369–3376, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Chassaing, J. D. Aitken, M. Malleshappa, and M. Vijay-Kumar, “Dextran sulfate sodium (DSS)-induced colitis in mice,” Current Protocols in Immunology, vol. 104, Unit 15.25, 2014. View at Publisher · View at Google Scholar
  45. D. K. Park and H.-J. Park, “Ethanol extract of Cordyceps militaris grown on germinated soybeans attenuates dextran-sodium-sulfate- (DSS-) induced colitis by suppressing the expression of matrix metalloproteinases and inflammatory mediators,” BioMed Research International, vol. 2013, Article ID 102918, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Suzuki, X. Sun, M. Nagata et al., “Analysis of intestinal fibrosis in chronic colitis in mice induced by dextran sulfate sodium,” Pathology International, vol. 61, no. 4, pp. 228–238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. F.-F. Chu, R. S. Esworthy, P. G. Chu et al., “Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes,” Cancer Research, vol. 64, no. 3, pp. 962–968, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Untergasser, I. Cutcutache, T. Koressaar et al., “Primer3-new capabilities and interfaces,” Nucleic Acids Research, vol. 40, no. 15, article e115, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. A. E. Bishop, R. Pietroletti, C. W. Taat, W. H. Brummelkamp, and J. M. Polak, “Increased populations of endocrine cells in Crohn's ileitis,” Virchows Archiv A: Pathological Anatomy and Histopathology, vol. 410, no. 5, pp. 391–396, 1987. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Ahonen, K. Kyosola, and O. Penttila, “Enterochromaffin cells and macrophages in ulcerative colitis and irritable colon,” Annals of Clinical Research, vol. 8, no. 1, pp. 1–7, 1976. View at Google Scholar · View at Scopus
  51. P. J. O'Connell, X. Wang, M. Leon-Ponte, C. Griffiths, S. C. Pingle, and G. P. Ahern, “A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells,” Blood, vol. 107, no. 3, pp. 1010–1017, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Dürk, E. Panther, T. Müller et al., “5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes,” International Immunology, vol. 17, no. 5, pp. 599–606, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Müller, T. Dürk, B. Blumenthal et al., “5-hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of dendritic cells in vitro and in vivo,” PLoS ONE, vol. 4, no. 7, Article ID e6453, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. A. M. Manicone and J. K. McGuire, “Matrix metalloproteinases as modulators of inflammation,” Seminars in Cell and Developmental Biology, vol. 19, no. 1, pp. 34–41, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. P. E. Van den Steen, P. Proost, A. Wuyts, J. Van Damme, and G. Opdenakker, “Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-α and leaves RANTES and MCP-2 intact,” Blood, vol. 96, no. 8, pp. 2673–2681, 2000. View at Google Scholar · View at Scopus
  56. G. Christoffersson, T. Waldén, M. Sandberg, G. Opdenakker, P.-O. Carlsson, and M. Phillipson, “Matrix metalloproteinase-9 is essential for physiological beta cell function and islet vascularization in adult mice,” American Journal of Pathology, vol. 185, no. 4, pp. 1094–1103, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. P. Garg, M. Rojas, A. Ravi et al., “Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: contrasting role of gelatinases in the pathogenesis of colitis,” Journal of Immunology, vol. 177, no. 6, pp. 4103–4112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Nighot, R. Al-Sadi, M. Rawat, S. Guo, D. M. Watterson, and T. Ma, “Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 309, no. 12, pp. G988–G997, 2015. View at Publisher · View at Google Scholar · View at Scopus
  59. M. de Bruyn, K. Machiels, J. Vandooren et al., “Infliximab restores the dysfunctional matrix remodeling protein and growth factor gene expression in patients with inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 20, no. 2, pp. 339–352, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. B. Von Lampe, B. Barthel, E.-O. Riecken, S. E. Coupland, and S. Rosewicz, “Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease,” Gut, vol. 47, no. 1, pp. 63–73, 2000. View at Publisher · View at Google Scholar · View at Scopus
  61. I. M. Clark, T. E. Swingler, C. L. Sampieri, and D. R. Edwards, “The regulation of matrix metalloproteinases and their inhibitors,” International Journal of Biochemistry and Cell Biology, vol. 40, no. 6-7, pp. 1362–1378, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. S. J. Crocker, A. Pagenstecher, and I. L. Campbell, “The TIMPs tango with MMPs and more in the central nervous system,” Journal of Neuroscience Research, vol. 75, no. 1, pp. 1–11, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. P. Devarajan, J. J. Johnston, S. S. Ginsberg, H. E. Van Wart, and N. Berliner, “Structure and expression of neutrophil gelatinase cDNA: identity with type IV collagenase from HT1080 cells,” Journal of Biological Chemistry, vol. 267, no. 35, pp. 25228–25232, 1992. View at Google Scholar · View at Scopus